J. Coote

发表

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

David M. Wilson, G. Drewes, D. Eberhard, 2015, Nature chemical biology.

Functional analysis of a human A1 adenosine receptor/green fluorescent protein/Gi1α fusion protein following stable expression in CHO cells

S. Rees, T. Palmer, G. Milligan, 1999, FEBS letters.

Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor.

T. Palmer, G. Stiles, J. Coote, 1997, Molecular pharmacology.

Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects

B. O'connor, C. Page, D. Spina, 2008, European Respiratory Journal.

Elevated expression of adenosine A1 receptor in bronchial biopsies from asthmatic subjects

C. Page, D. Spina, O. Connor, 2007 .

GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist

T. Kenakin, D. W. Gray, A. Wise, 2006, British journal of pharmacology.

Stimulation of the secretion of plasminogen activator from activated murine macrophages by microtubule disrupting agents and deuterium oxide.

J. Coote, I. F. Skidmore, H. Humphray, 1980, Biochemical pharmacology.

Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library.

J. Arends, H. Hoogenboom, F. V. van Nieuwenhoven, 1999, European journal of biochemistry.

Potent antagonism by BIM‐23056 at the human recombinant somatostatin sst5 receptor

W. Feniuk, G. Wilkinson, L. Sellers, 1996, British journal of pharmacology.

Somatostatin displayed on filamentous phage as a receptor‐specific agonist

J. Arends, H. Hoogenboom, J. Lutgerink, 1998, British journal of pharmacology.